WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial
More than a dozen Utah legislators on Wednesday, November 20, held a breakfast meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at the state capitol.
Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy
Agreement will expand worldwide access and better position Myriad’s GIS as a potential companion diagnostic across multiple potential tumor types
Four Integration Methods Aim to Combat Healthcare-Associated Infections & Improve Device Performance
SINTX TECHNOLOGIES AND NED MEDICAL PARTNER TO ADVANCE CUTTING-EDGE CERAMIC MICROSPHERE MEDICAL DEVICES FOR CANCER TREATMENT
First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities
Seek Labs Announces Partnership with Cerbrec
Update call scheduled for November 20th at 7:30 a.m. Eastern with anticipated close
OpenPhenom is a non-commercial, publicly available foundation model built on microscopy data that has set the new “gold standard” outperforming CellProfiler
Novel targets for managing inflammation hold the promise of greater efficacy and safety for diseases not widely viewed as inflammatory in nature.
SneakPeek®, the first at-home early fetal sex test for use at six weeks, is now available at over 8,800 retail locations nationwide.
BioUtah yesterday held its 2024 Utah Life Sciences Summit, sponsored by Mayer Brown. Every year, the Summit is the largest gathering of Utah’s life sciences industry. This year was no exception. A distinguished line-up of industry leaders and inspiring speakers addressed a packed house. Utah Governor Spencer Cox welcomed attendees to kick off the day-long […]
Ross Southern Laboratories (RSL) proudly announces its ISO 9001 certification for its Quality Management System
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cellino Biotech, Inc., a biotechnology company advancing autonomous, closed biomanufacturing for personalized regenerative medicines, today announced the appointment of Chris Gibson to the company’s Board of Directors. “Cellino’s proprietary technology stack, including optical bioprocessing, closed cassettes, and image-guided co-pilots, has the potential to transform healthcare and bring potentially curative therapies to millions of […]
SALT LAKE CITY and SUNNYVALE, Calif., Oct. 21, 2024 /PRNewswire/ — Recursion, a leading TechBio company decoding biology to radically improve lives, and Google Cloud today announced an expanded collaboration leveraging Google Cloud’s technologies to support Recursion’s drug discovery platform. This strategic partnership includes exploring generative AI capabilities, including Gemini models, to support the RecursionOS, […]
The University of Utah, one of the nation’s leading research universities, has just announced the launch of a new laboratory called the Applied MedicalEngineering (AME) Lab. The AME Lab’s ambitious mission is to create cutting-edge medical technologies designed to deliver life-saving care to any patient with any injury at any location for any duration. The […]
VALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide radioligand therapies focused on difficult to treat cancers, today announced a supply agreement to advance the development of Starget’s Smart Targeted Radioligands (STRs). The supply […]
Myriad’s MyRisk® test is the first hereditary cancer test integrated into Flatiron’s OncoEMR® SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with Flatiron Health, a leading health tech company dedicated to expanding the possibilities of point of care […]
LEHI, Utah, Oct. 14, 2024 /PRNewswire/ — Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for inflammatory and neurodegenerative diseases, today announced that David J. Bearss, Ph.D., President and CEO of Halia Therapeutics, will participate in a panel at the BIO Investor Forum taking place October 15-16, 2024, in […]
Canary Ambient™ enables actionable insights into patient-clinician dialogues, tracking speech patterns, and delivering real-time evaluations of cognitive and behavioral health conditions PROVO, Utah, Oct. 16, 2024 /PRNewswire/ — Canary Speech, a leader in vocal biomarker technology, has announced today the launch of Canary Ambient™, an API-first solution designed for healthcare and contact centers, which offers a […]
SALT LAKE CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) — Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic partnership with jscreen™, a national organization that delivers education and access to preventative genetic testing with a focus on high-risk populations. The collaboration combines the strengths of Myriad’s high-quality […]
Utah-based Canyon Labs announces its strategic acquisition of Life Pack Labs in California, broadening its service offerings and enhancing its position as an industry leader in medical device and pharmaceutical compliance testing. SALT LAKE CITY, October 8, 2024 (Newswire.com) – Canyon Labs, a leading medical device & pharmaceutical consulting, sterility assurance, analytical chemistry and package […]
Researchers at Utah State University, led by Professor Zhongde Wang and collaborating with teams at University of Texas Medical Branch and University of Pittsburgh, respectively, have secured two grants from the National Institutes of Health (NIH) totaling more than $4 million in recent months to advance the understanding of two important global health threats. In […]
BioUtah and five BioUtah member companies participated in the Governor’s trade mission to Korea and Japan organized by World Trade Center Utah. Led by BioUtah president and CEO, Kelvyn Cullimore, the life sciences delegation included Dwight Egan, Seth Egan and Richard Abbott of CoDiagnostics, Mike Kirkness and Lucas Bennink of 3Helix, Taylor Avei of Halia […]
SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor’s Office of Economic Opportunity, as part of the latest World Trade Center (WTC) Utah trade […]
BioUtah’s VP for Government Affairs, Denise Bell, along with a coalition of patient advocates, life sciences executives, pharmacists, physicians, oncologists, and community organizations, held a lunch meeting with Representatives Blake Moore (R-UT) and Celeste Maloy (R-UT) October 1 to discuss the dangers of giving pharmacy benefit managers (PBMs) command over how much patients pay for […]
BioUtah’s annual membership appreciation BBQ was held yesterday at the Gateway’s Hidden Gem Patio. The event was a great way for the nearly 200 registrants to network with colleagues and make new connections. Prior to the BBQ, an executive reception was held, with several BioUtah Board members present. Also, in conjunction with the BBQ, the […]
Representatives John Curtis (R-UT) and Blake Moore (R-UT) toured bioMérieux.
BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.
Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to even more parents across the globe.
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies.
